Meeting Coverage
NACLC
North America Conference on Lung Cancer
Reduced severe neutropenia and less need for supportive care with trilaciclib
Latest NACLC Meeting Coverage
Nivolumab-ipilimumab with two cycles of chemotherapy improved survival, regardless of histology or PD-L1 status
October 17, 2020
Latest Oncology/Hematology Meeting Coverage
-
ASTRO: American Society for Radiation Oncology
September 2024
-
ESMO: European Society for Medical Oncology
September 2024
-
ASCO: American Society of Clinical Oncology
May 2024
-
AACR: American Association for Cancer Research
April 2024